Welcome to your partner for life science consulting, specializing in pharmaceutical impurities.

Led by Clarence Wybon, a life science innovator, bioscience engineer and organic chemist with 14 years of international experience.

About my experience

I have been working on end-to-end nitrosamine risk management for 6 years.

‍ ‍

“Let the science lead.”

Ready for FDA’s New Nitrosamine Guidance?

Are you prepared to implement the US FDA’s “September 24, 2026: Application of Less-Than-Lifetime Adjustment to Nitrosamine Impurities” across your portfolio?

I deliver application-ready LTL justification packages.